William Blair & Company
VIRX

William Blair & Company’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

William Blair & Company’s Portfolio VIRX Stock Details VIRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$75.7K Hold
2022
Q3 		$221K Hold
2022
Q2 		$201K Hold
2022
Q1 		$247K Hold
2021
Q4 		$189K Hold
2021
Q3 		$416K Hold
2021
Q2 		$588K Hold
2021
Q1 		$480K Buy